202 related articles for article (PubMed ID: 15826579)
1. [Association between microsatellite instability and clinico-pathological characteristics in sporadic colon cancer].
Guerrero D; Balen E; Martínez-Peñuela JM; García-Foncillas J; Larrinaga B; Caballero MC; Herrera J; Lera JM
Med Clin (Barc); 2005 Apr; 124(12):441-6. PubMed ID: 15826579
[TBL] [Abstract][Full Text] [Related]
2. Microsatellite Instability was not Associated with Survival in Stage III Colon Cancer Treated with Adjuvant Chemotherapy of Oxaliplatin and Infusional 5-Fluorouracil and Leucovorin (FOLFOX).
Kim JE; Hong YS; Kim HJ; Kim KP; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Kim JH; Kim TW
Ann Surg Oncol; 2017 May; 24(5):1289-1294. PubMed ID: 27853901
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial.
Klingbiel D; Saridaki Z; Roth AD; Bosman FT; Delorenzi M; Tejpar S
Ann Oncol; 2015 Jan; 26(1):126-132. PubMed ID: 25361982
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of clinicopathological features and prognosis of sporadic synchronous multiple primary colorectal cancers].
Qin ZF; Xu GH; Zhou SQ; Zheng PW; Zhu YP; Ju HX; Li DC; Ma DN
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1171-1178. PubMed ID: 38110279
[No Abstract] [Full Text] [Related]
5. Molecular profiling of the colon cancer in South-Eastern Romania: Results from the MERCUR study.
Popescu RC; Tocia C; Brînzan C; Cozaru GC; Deacu M; Dumitru A; Leopa N; Mitroi AF; Nicolau A; Dumitru E
Medicine (Baltimore); 2021 Jan; 100(1):e24062. PubMed ID: 33429770
[TBL] [Abstract][Full Text] [Related]
6. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
[TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancer.
Oh SY; Kim DY; Kim YB; Suh KW
World J Surg; 2013 Oct; 37(10):2497-503. PubMed ID: 23754140
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal instability in microsatellite-unstable and stable colon cancer.
Trautmann K; Terdiman JP; French AJ; Roydasgupta R; Sein N; Kakar S; Fridlyand J; Snijders AM; Albertson DG; Thibodeau SN; Waldman FM
Clin Cancer Res; 2006 Nov; 12(21):6379-85. PubMed ID: 17085649
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients.
Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG
Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
11. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
Chouhan H; Sammour T; Thomas ML; Moore JW
J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
[TBL] [Abstract][Full Text] [Related]
13. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
Mohan HM; Ryan E; Balasubramanian I; Kennelly R; Geraghty R; Sclafani F; Fennelly D; McDermott R; Ryan EJ; O'Donoghue D; Hyland JM; Martin ST; O'Connell PR; Gibbons D; Winter D; Sheahan K
Eur J Surg Oncol; 2016 Nov; 42(11):1680-1686. PubMed ID: 27370895
[TBL] [Abstract][Full Text] [Related]
14. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses.
Kim SY; Choi YY; An JY; Shin HB; Jo A; Choi H; Seo SH; Bang HJ; Cheong JH; Hyung WJ; Noh SH
Int J Cancer; 2015 Aug; 137(4):819-25. PubMed ID: 25614197
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer.
Lamberti C; Lundin S; Bogdanow M; Pagenstecher C; Friedrichs N; Büttner R; Sauerbruch T
Int J Colorectal Dis; 2007 Feb; 22(2):145-52. PubMed ID: 16724208
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
[TBL] [Abstract][Full Text] [Related]
17. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability.
Gafà R; Maestri I; Matteuzzi M; Santini A; Ferretti S; Cavazzini L; Lanza G
Cancer; 2000 Nov; 89(10):2025-37. PubMed ID: 11066042
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial.
Tikidzhieva A; Benner A; Michel S; Formentini A; Link KH; Dippold W; von Knebel Doeberitz M; Kornmann M; Kloor M
Br J Cancer; 2012 Mar; 106(6):1239-45. PubMed ID: 22353804
[TBL] [Abstract][Full Text] [Related]
19. Low microsatellite instability is associated with poor prognosis in stage C colon cancer.
Kohonen-Corish MR; Daniel JJ; Chan C; Lin BP; Kwun SY; Dent OF; Dhillon VS; Trent RJ; Chapuis PH; Bokey EL
J Clin Oncol; 2005 Apr; 23(10):2318-24. PubMed ID: 15800322
[TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers.
Sinicrope FA; Rego RL; Foster N; Sargent DJ; Windschitl HE; Burgart LJ; Witzig TE; Thibodeau SN
Am J Gastroenterol; 2006 Dec; 101(12):2818-25. PubMed ID: 17026563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
